pubmed-article:16985364 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16985364 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
pubmed-article:16985364 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:16985364 | lifeskim:mentions | umls-concept:C0030193 | lld:lifeskim |
pubmed-article:16985364 | lifeskim:mentions | umls-concept:C0262950 | lld:lifeskim |
pubmed-article:16985364 | lifeskim:mentions | umls-concept:C0027627 | lld:lifeskim |
pubmed-article:16985364 | lifeskim:mentions | umls-concept:C0772051 | lld:lifeskim |
pubmed-article:16985364 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:16985364 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:16985364 | pubmed:dateCreated | 2006-9-20 | lld:pubmed |
pubmed-article:16985364 | pubmed:abstractText | Sm-153 EDTMP is an effective treatment of painful bone metastases from different neoplasms. However, there are few studies describing clinical experience with this therapeutic modality. The aim of this clinical study was to evaluate the efficacy of Sm-153 EDTMP in a group of patients with skeletal metastases and poor pain control with conventional therapies. | lld:pubmed |
pubmed-article:16985364 | pubmed:language | eng | lld:pubmed |
pubmed-article:16985364 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16985364 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16985364 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16985364 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16985364 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16985364 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16985364 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16985364 | pubmed:month | Oct | lld:pubmed |
pubmed-article:16985364 | pubmed:issn | 0363-9762 | lld:pubmed |
pubmed-article:16985364 | pubmed:author | pubmed-author:EspinosaEnriq... | lld:pubmed |
pubmed-article:16985364 | pubmed:author | pubmed-author:BarónManuel... | lld:pubmed |
pubmed-article:16985364 | pubmed:author | pubmed-author:ZamoraPilarP | lld:pubmed |
pubmed-article:16985364 | pubmed:author | pubmed-author:CasteloBeatri... | lld:pubmed |
pubmed-article:16985364 | pubmed:author | pubmed-author:RedondoAndrés... | lld:pubmed |
pubmed-article:16985364 | pubmed:author | pubmed-author:CoyaJuanJ | lld:pubmed |
pubmed-article:16985364 | pubmed:author | pubmed-author:CoronadoMónic... | lld:pubmed |
pubmed-article:16985364 | pubmed:author | pubmed-author:CoutoRosa MRM | lld:pubmed |
pubmed-article:16985364 | pubmed:author | pubmed-author:MarinMaria... | lld:pubmed |
pubmed-article:16985364 | pubmed:author | pubmed-author:LilloMaria... | lld:pubmed |
pubmed-article:16985364 | pubmed:author | pubmed-author:FrutosLauraL | lld:pubmed |
pubmed-article:16985364 | pubmed:author | pubmed-author:CurtoLuis M... | lld:pubmed |
pubmed-article:16985364 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16985364 | pubmed:volume | 31 | lld:pubmed |
pubmed-article:16985364 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16985364 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16985364 | pubmed:pagination | 605-10 | lld:pubmed |
pubmed-article:16985364 | pubmed:meshHeading | pubmed-meshheading:16985364... | lld:pubmed |
pubmed-article:16985364 | pubmed:meshHeading | pubmed-meshheading:16985364... | lld:pubmed |
pubmed-article:16985364 | pubmed:meshHeading | pubmed-meshheading:16985364... | lld:pubmed |
pubmed-article:16985364 | pubmed:meshHeading | pubmed-meshheading:16985364... | lld:pubmed |
pubmed-article:16985364 | pubmed:meshHeading | pubmed-meshheading:16985364... | lld:pubmed |
pubmed-article:16985364 | pubmed:meshHeading | pubmed-meshheading:16985364... | lld:pubmed |
pubmed-article:16985364 | pubmed:meshHeading | pubmed-meshheading:16985364... | lld:pubmed |
pubmed-article:16985364 | pubmed:meshHeading | pubmed-meshheading:16985364... | lld:pubmed |
pubmed-article:16985364 | pubmed:meshHeading | pubmed-meshheading:16985364... | lld:pubmed |
pubmed-article:16985364 | pubmed:meshHeading | pubmed-meshheading:16985364... | lld:pubmed |
pubmed-article:16985364 | pubmed:meshHeading | pubmed-meshheading:16985364... | lld:pubmed |
pubmed-article:16985364 | pubmed:meshHeading | pubmed-meshheading:16985364... | lld:pubmed |
pubmed-article:16985364 | pubmed:meshHeading | pubmed-meshheading:16985364... | lld:pubmed |
pubmed-article:16985364 | pubmed:meshHeading | pubmed-meshheading:16985364... | lld:pubmed |
pubmed-article:16985364 | pubmed:meshHeading | pubmed-meshheading:16985364... | lld:pubmed |
pubmed-article:16985364 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16985364 | pubmed:articleTitle | Clinical role of Sm-153 EDTMP in the treatment of painful bone metastatic disease. | lld:pubmed |
pubmed-article:16985364 | pubmed:affiliation | Nuclear Medicine Department, La Paz University Hospital, Madrid, Spain. coronadominica@hotmail.com | lld:pubmed |
pubmed-article:16985364 | pubmed:publicationType | Journal Article | lld:pubmed |